R M Bijlsma
Overview
Explore the profile of R M Bijlsma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rademaker L, Gal R, May A, Batenburg M, van der Leij F, Bijlsma R, et al.
Breast
. 2025 Feb;
80:104416.
PMID: 39978152
Many women with breast cancer prematurely discontinue adjuvant endocrine therapy, leading to increased mortality. We performed a cross-sectional survey (n = 456) within the Dutch UMBRELLA-cohort to gain insight into...
2.
de Boo L, Jozwiak K, Ter Hoeve N, van Diest P, Opdam M, Wang Y, et al.
ESMO Open
. 2024 Mar;
9(3):102923.
PMID: 38452438
Background: In the absence of prognostic biomarkers, most patients with early-stage triple-negative breast cancer (eTNBC) are treated with combination chemotherapy. The identification of biomarkers to select patients for whom treatment...
3.
Vrancken Peeters N, Vlooswijk C, Bijlsma R, Kaal S, Kerst J, Tromp J, et al.
ESMO Open
. 2024 Jan;
9(2):102234.
PMID: 38281325
Background: With increasing survival rates of adolescents and young adults (AYAs) with breast cancer, health-related quality of life (HRQoL) becomes more important. An important aspect of HRQoL is sexual QoL....
4.
Batenburg M, Mink van der Molen D, van der Leij F, Doeksen A, van Dalen T, Schoenmaeckers E, et al.
Int J Radiat Oncol Biol Phys
. 2022 Nov;
115(5):1181-1191.
PMID: 36402357
Purpose: Our purpose was to assess the prevalence of patient-reported symptoms of local late toxicity in patients with irradiated breast cancer and determine the association between late toxicity and quality...
5.
Opdam M, van der Noort V, Kleijn M, Glas A, Mandjes I, Kleiterp S, et al.
Breast Cancer Res Treat
. 2022 May;
194(2):265-278.
PMID: 35587322
Purpose: Guidelines recommend endocrine treatment for estrogen receptor-positive (ER+) breast cancers for up to 10 years. Earlier data suggest that the 70-gene signature (MammaPrint) has potential to select patients that...
6.
Staal D, Vlooswijk C, Mols F, Lidington E, van der Graaf W, Bijlsma R, et al.
Support Care Cancer
. 2020 May;
29(1):409-416.
PMID: 32377841
Background: Insight into the causes of colorectal cancer (CRC) in adolescent and young adult (AYA) patients is limited. Without definitive information, patients often shape their own beliefs on the cause...
7.
Bijlsma R, Wouters R, Wessels H, May A, Ausems M, Voest E, et al.
Psychooncology
. 2018 Feb;
27(4):1327-1333.
PMID: 29471587
Objective: Next-generation sequencing (NGS) is increasingly being employed in the context of personalized cancer treatment. Anticipating unsolicited findings that may arise during a NGS procedure is a key consideration; however,...
8.
Bijlsma R, Groenendijk P, Blind M, Hoekstra A
Water Sci Technol
. 2007 Sep;
56(6):1-9.
PMID: 17898438
Uncertainty analysis for large-scale model studies is a challenging activity that requires a different approach to uncertainty analysis at a smaller scale. However, in river basin studies, the practice of...